Lacrimedics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lacrimedics, Inc. - overview
Established
1984
Location
DuPont, WA, US
Primary Industry
Medical Devices & Equipment
About
Based in Washington, US, and founded in 1984 by Ophthalmologist, Robert S. Herrick, M. D. Lacrimedics, Inc.
operates as a designer, developer, and manufacturer of occlusion therapy devices for the treatment of dry eye disease and underlying symptoms. In March 2021, Innovia Medical LLC Group, a portfolio company of Shore Capital Partners, acquired Lacrimedics, Inc. As of September 2022, the company products are distributed throughout the world in over 45 countries. Lacrimedics, Inc.
's line of occlusion therapy products includes dissolvable VisiPlug™ Lacrimal plug, collagen plugs for the Lacrimal efficiency test, OPAQUE Herrick Lacrimal plugs, ComfortTip™ punctal occluder, AccuFlo™ punctal occluder, and API - Angled-Tip plug insertion forceps designed specifically to improve insertion in eyes of the patient.
Current Investors
Shore Capital Partners, Innovia Medical, Inc.
Primary Industry
Medical Devices & Equipment
Sub Industries
Optometrists & Opticians Products and Services, Therapeutic Devices
Website
www.lacrimedics.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Lacrimedics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Lacrimedics, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.